Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Cocco

Showing results (121-130 of 267) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis and Related Disorders|December 7, 2016
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gaitIlaria Pacifici, Manuela Galli, Ana Francisca Rozin Kleiner, et al.
Cerebellum (London, England)|August 4, 2023
Comparison of Two Therapeutic Approaches of Cerebellar Transcranial Direct Current Stimulation in a Sardinian Family Affected by Spinocerebellar Ataxia 38: a Clinical and Computerized 3D Gait Analysis StudyAngela Sanna, Massimiliano Pau, Giuseppina Pilia, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|July 16, 2013
Overlapping syndromes in laminopathies: a meta-analysis of the reported literatureNicola Carboni, Luisa Politano, Matteo Floris, et al.
Current Neuropharmacology|September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple SclerosisAntonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
Journal of Neuroimmunology|November 21, 2017
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapsesSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
Current Neuropharmacology|September 24, 2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple SclerosisEttore Dolcetti, Pietro Annovazzi, Marinella Clerico, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025
Pediatric Onset Multiple Sclerosis (POMS): Exploring phenotypic characterization and pubertal influences in modulating the disease activity from the Danish MS Registry (DMSR)Silvy Pilotto, Luigi Pontieri, Helle Hvilsted Nielsen, et al.
Annals of Neurology|February 25, 2006
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosisNicola De Stefano, Eleonora Cocco, Marina Lai, et al.
Plos One|April 18, 2012
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in SardiniaEleonora Cocco, Claudia Sardu, Enrico Pieroni, et al.
Journal of the Neurological Sciences|January 20, 2015
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patientsJessica Frau, Davide Cossu, Giancarlo Coghe, et al.
Pageof 27

Showing results (121-130 of 267) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis and Related Disorders|December 7, 2016
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gaitIlaria Pacifici, Manuela Galli, Ana Francisca Rozin Kleiner, et al.
Cerebellum (London, England)|August 4, 2023
Comparison of Two Therapeutic Approaches of Cerebellar Transcranial Direct Current Stimulation in a Sardinian Family Affected by Spinocerebellar Ataxia 38: a Clinical and Computerized 3D Gait Analysis StudyAngela Sanna, Massimiliano Pau, Giuseppina Pilia, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|July 16, 2013
Overlapping syndromes in laminopathies: a meta-analysis of the reported literatureNicola Carboni, Luisa Politano, Matteo Floris, et al.
Current Neuropharmacology|September 16, 2024
Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple SclerosisAntonio Bruno, Pietro Annovazzi, Marinella Clerico, et al.
Journal of Neuroimmunology|November 21, 2017
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapsesSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
Current Neuropharmacology|September 24, 2024
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple SclerosisEttore Dolcetti, Pietro Annovazzi, Marinella Clerico, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025
Pediatric Onset Multiple Sclerosis (POMS): Exploring phenotypic characterization and pubertal influences in modulating the disease activity from the Danish MS Registry (DMSR)Silvy Pilotto, Luigi Pontieri, Helle Hvilsted Nielsen, et al.
Annals of Neurology|February 25, 2006
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosisNicola De Stefano, Eleonora Cocco, Marina Lai, et al.
Plos One|April 18, 2012
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in SardiniaEleonora Cocco, Claudia Sardu, Enrico Pieroni, et al.
Journal of the Neurological Sciences|January 20, 2015
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patientsJessica Frau, Davide Cossu, Giancarlo Coghe, et al.
Pageof 27